ClinicalTrials.gg
Not yet recruitingNCT07686003FLOW-PRADAUpdated Jul 6, 2026

Flow Dynamics During Simulated Hemostasis at the Proximal and Distal Radial Arteries

An observational study in Hemostasis of Arterial Punctures, sponsored by Wonju Severance Christian Hospital. Not yet recruiting at 1 site in South Korea. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by Wonju Severance Christian Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
220
Sex
All
01

Study summary

Transradial access (TRA) has been widely adopted for coronary angiography and percutaneous coronary intervention, as it has been shown to significantly reduce bleeding complications, vascular complications, and mortality compared with transfemoral access (TFA). Based on this evidence, recent international guidelines recommend TRA as the preferred access strategy.

Radial artery occlusion (RAO), a potential complication following TRA, is often clinically silent and therefore underestimated. However, RAO has important clinical implications, particularly in patients who may require repeated coronary procedures, those in whom the radial artery may be used as a conduit for coronary artery bypass grafting, or patients with chronic kidney disease requiring arteriovenous fistula formation. Therefore, maintaining radial artery patency after the procedure is of considerable clinical importance.

Distal radial access (DRA), which utilizes the radial artery at the anatomical snuffbox, is a relatively recent approach. Multiple studies and meta-analyses have demonstrated that DRA provides comparable procedural success rates to TRA while significantly reducing bleeding complications and the incidence of RAO. Notably, despite the generally accepted association between smaller vessel diameter and higher risk of occlusion, DRA paradoxically shows a lower incidence of RAO. The underlying mechanism for this observation remains incompletely understood.

Sgueglia et al. evaluated peak systolic velocity using Doppler ultrasonography under conditions of arterial compression and reported that antegrade blood flow was better preserved during distal radial artery compression compared with proximal radial artery compression. This finding suggests a potential mechanistic explanation for the lower incidence of RAO observed with DRA.

However, there is a paucity of studies that systematically evaluate hemodynamic changes under simulated real-world hemostatic conditions at both proximal and distal radial arteries.

Therefore, the aim of this study is to quantitatively assess hemodynamic changes induced by simulated occlusive hemostasis at the proximal and distal radial arteries using Doppler ultrasonography, and to elucidate the mechanisms underlying the lower incidence of RAO observed with DRA.

02

Conditions studied

  • Hemostasis of Arterial Punctures

Keywords

  • Distal radial access
  • Hemostasis
03

In context

Lead sponsor

Wonju Severance Christian Hospital is the lead sponsor of 43 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults (≥19 years) scheduled for coronary angiography for atypical chest pain, stable angina, or acute coronary syndrome, undergoing pre-procedural transthoracic echocardiography, with palpable proximal and distal radial arteries; excluding those with cardiogenic shock, prior distal radial coronary angiography before echocardiography, inability/refusal to consent, ipsilateral arteriovenous fistula, or pregnancy/breastfeeding.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

A. Adults aged ≥19 years B. Patients scheduled for coronary angiography due to atypical chest pain, stable angina, or acute coronary syndrome C. Patients undergoing transthoracic echocardiography for assessment of cardiac function prior to coronary angiography D. Palpable proximal and distal radial arteries

Exclusion criteria

Exclusion Criteria:

A. Cardiogenic shock B. Patients who have undergone coronary angiography via distal radial access prior to echocardiographic evaluation C. Refusal or inability to provide D. Presence of an ipsilateral arteriovenous fistula E. Pregnant or breastfeeding women

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
220 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patent hemostasis of distal radial artery

    Patent hemostasis of distal radial artery using TR band

    Device: Air-filled hemostatic band

  • Patent hemostasis of proximal radial artery

    Patent hemostasis of proximal radial artery using TR band

    Device: Air-filled hemostatic band

Interventions

  • DeviceAir-filled hemostatic band

    Simulated patent hemostasis using air-filled TR band

06

What researchers measure

Primary outcomes

  1. Difference in end-diastolic velocity

    Difference in end-diastolic velocity between proximal and distal radial arteries during patent hemostasis by Doppler ultrasound

    Time frame: Periprocedural

Secondary outcomes

  1. Flow preservation ratio

    Flow preservation ratio in proximal and distal radial arteries

    Time frame: Periprocedural

  2. Blood flow volume

    Blood flow volume in proximal and distal radial arteries

    Time frame: Periprocedural

  3. Flow volume per beat

    Flow volume per beat in proximal and distal radial arteries

    Time frame: Periprocedural

  4. Pulsatility index

    Pulsatility index in proximal and distal radial arteries

    Time frame: Periprocedural

  5. Resistance index

    Resistance index in proximal and distal radial arteries

    Time frame: Periprocedural

  6. Peak systolic velocity

    Peak systolic velocity in proximal and distal radial arteries

    Time frame: Periprocedural

  7. Velocity time integral

    Velocity time integral in proximal and distal radial arteries

    Time frame: Periprocedural

  8. Radial artery occlusion

    Radial artery occlusion

    Time frame: up to 1 month

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jul 2026; primary completion for Dec 2026, 5 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2026
First posted
Jul 6, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jul 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07686003
Lead sponsor
Wonju Severance Christian Hospital
Collaborators
Whanin Pharmaceutical Company
Responsible party
Jung-Woo Son (Assistant professor, Wonju Severance Christian Hospital) — Principal investigator
First posted
Jul 6, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 6, 2026

Study contacts

Jung-Woo Son
Contact
soneycar@gmail.com
+82-33-741-0910
Jun-Won Lee, MD, PhD
Contact
ljwcardio@yonsei.ac.kr
Jung-Woo Son
principal investigator · Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion